Title |
At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer
|
---|---|
Published in |
Cancer Immunology Research, March 2021
|
DOI | 10.1158/2326-6066.cir-21-0008 |
Pubmed ID | |
Authors |
Marina Chiara Garassino, Antoni Ribas |
X Demographics
The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 26% |
Brazil | 1 | 5% |
Italy | 1 | 5% |
Poland | 1 | 5% |
Unknown | 11 | 58% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 10 | 53% |
Scientists | 5 | 26% |
Practitioners (doctors, other healthcare professionals) | 3 | 16% |
Science communicators (journalists, bloggers, editors) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 68 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 10 | 15% |
Student > Bachelor | 9 | 13% |
Other | 7 | 10% |
Student > Ph. D. Student | 4 | 6% |
Student > Master | 4 | 6% |
Other | 11 | 16% |
Unknown | 23 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 31% |
Nursing and Health Professions | 6 | 9% |
Agricultural and Biological Sciences | 5 | 7% |
Biochemistry, Genetics and Molecular Biology | 2 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Other | 6 | 9% |
Unknown | 26 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2022.
All research outputs
#2,757,142
of 23,523,017 outputs
Outputs from Cancer Immunology Research
#304
of 1,447 outputs
Outputs of similar age
#72,136
of 421,129 outputs
Outputs of similar age from Cancer Immunology Research
#15
of 54 outputs
Altmetric has tracked 23,523,017 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,447 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,129 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.